Dolby Laboratories, Inc. vs Tempus AI — how do they compare? Dolby Laboratories, Inc. trades at $48.49 (market cap $4.59B), while Tempus AI trades at $58.72 (market cap $10.54B). The key difference: Tempus AI is far larger — about 2.3× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.91% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| DLB | TEM | |
|---|---|---|
Market Cap | $4.59B | $10.54B |
Sector | Industrials | Broad Market / Factor |
52-Week High | $76.79 | $103.25 |
52-Week Low | $48.51 | $42.37 |
Enterprise Value | $4.04B | $11.21B |
Dividend Yield | 2.91% | — |
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $49.36, down 0.88% on the day, with a bearish technical outlook. The company maintains strong fundamentals, including a P/E of 19.59, a net income margin of 17.85%, and consistent earnings beats in recent quarters. Recent news highlights include its role in powering immersive audio for the FIFA World Cup 2026 coverage and recognition as a top supplier by General Motors.
The stock presents a value opportunity given its discount to the analyst consensus price target of $87.50, but faces near-term headwinds from bearish technical signals and cyclical end-market exposure. Upside potential hinges on continued licensing growth and execution, while risks include market sentiment and competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →